Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronies disease: a double-blind, placebo controlled, randomized study
Comprehensive documentation supports continuity of care while demonstrating thoughtful clinical decision-making should questions arise later
With respect to the primary endpoint of A1C reduction from baseline, dulaglutide 4.5 mg was superior to the 1.5 mg dose at Week 36 under the treatment regimen estimand (mean change from baseline [mean baseline 8.6%]: dulaglutide 1.5 mg -1.54%, dulaglutide 4.5 mg -1.77%
Through months two and three the anti-aging phase the peptides stimulated local collagen and elastin
Nitric oxide and peroxynitrite in health and disease
Aromatic amino acids including tyrosine, tryptophan, and phenylalanine absorb UV radiation, leading to structural modifications